• Generic Drug Debates

    Huffington Post | A tenent of Obama's health care plan was cheaper generic drug options, but that's proving easier said than done. Approving biosimilars is a complex and drawn-out process.

    Mar 5, 2012

  • CDC Budget Cuts Could Put Agency at Risk

    Nature | President Obama's cuts in CDC funding could spell disaster for the agency. The CDC has had its overall budget cut by 20% since 2010. Some of the cuts are meant to be made up by other government spending, but some of those sources' budgets are not yet approved by Congress. 

    Mar 4, 2012

  • The Myth of the Low-Hanging Fruit

    Forbes | The "low-hanging fruit" that fueled biotech and pharma in the past is a myth, says John LaMattina. R&D isn't emerging from a golden age of discovery; research has always been hard and the blockbusters of yesterday came at the expense of "spectacular failures."

    Mar 4, 2012

  • Insight Genetics Pursues Diagnostic for Lung Cancer

    Tennessean | Insight Genetics just signed a key distribution agreement with Qiagen to bring its diagnostic test for a genetic mutation for Anaplastic Lymphoma Kinase (ALK) to market.

    Mar 4, 2012

  • The Statin-Diabetes Link

    New York Times | The Food and Drug Administration warned last week that statins could be causing a sharp increase in Type 2 diabetes and contributing to memory loss among users. 

    Mar 4, 2012

  • Buetow Moves On from caBIG

    Bio-IT World | On March 5, Kenneth Buetow, former director of the Center for Biomedical Informatics and Information Technology at the National Cancer Institute and instrumental in NCI's Cancer Biomedical Informatics Grid, or caBIG program, is joining Arizona State University as director of Computational Sciences and Informatics in the Complex Adaptive Systems Initiative.

    Mar 1, 2012

  • February Free Trials and Downloads

    Bio-IT World | Free trials & downloads featuring tox screening, ELNs, data visualization, digital signatures, plasmid mapping, and more.  

    Mar 1, 2012

  • Lilly to Spend $10m on Academic Collaborations

    Indy Star | Eli Lilly is planning to spend about $10 million on academic partnerships that would support its drug discovery efforts. This week, Lilly announced the first three projects chosen for funding. 

    Feb 29, 2012

  • Rare Disease Day, Common Focus

    Bio-IT World Roundup | In honor of "Rare Disease Day" yesterday (Feb 29, get it?), rare diseases garnered quite a bit of attention from the Rare Genomics Institute, a Rare Diseases Clinical Exome Challenge, and the Clinic for Special Children.

    Feb 29, 2012

  • Instruct Network Links Structural Biologists in Europe

    Nature News | The Instruct Network launched last week in Europe, allows structural biologists to share the tools they need to model the cell. With a goal of having a "Google Cell" approach (similar to Google Earth), 22 structural-biology centers linked equipment and expertise.

    Feb 29, 2012

  • BGI, Agilent Announce Collaboration

    Asian Scientist | BGI and Agilent today announced a collaborative effort to develop new technologies for genome-wide association studies.

    Feb 29, 2012

  • Thomson Reuters Releases APIs for Cortellis Life Sciences Platform

    Bio-IT World | Thomson Reuters announced a series of APIs (application programming interfaces) for its Cortellis life sciences platform this morning called Cortellis for Informatics. The APIs will give customers direct access to the Cortellis content.  

    Feb 28, 2012

  • 2012 Benjamin Franklin Award Finalists Named

    Bio-IT World | Bioinformatics.org has announced the finalists in the 2012 Benjamin Franklin Award: Helen Berman, Rutgers University; Carole Goble, University of Manchester; Eugene V. Koonin, NCBI/NLM/NIH; Heng Li, Broad Institute; John Quackenbush, Dana-Farber Cancer Institute & Harvard School of Public Health; Bruno Sobral, Virginia Bioinformatics Institute; and Janet Thornton, European Bioinformatics Institute. 

    Feb 27, 2012

  • Modeling microRNAs

    Bio-IT World | MicroRNAs (miRNAs) work by modifying gene expression at the post-translational level across a range of species, from plants to worms to humans, and Stephen Cohen's lab at the Institute of Molecular and Cell Biology (IMCB) in Singapore uses the fruit fly as a genetic model for the study of cancer, metabolic disease and neurodegeneration and in recent years has focused on understanding the biological functions of miRNAs in this context.  

    Feb 27, 2012

  • Roche Extends Illumina Offer

    Businessweek | Yesterday, Roche extended its offering for Illumina until March 23 after failing to win over shareholders with the $44.50/share offer that expired on February 24. Roche has been making offers for the biotech since January 25.

    Feb 27, 2012

  • Ed Liu on JAX's New Genomic Medicine Institute

    Connecticut Mirror | The Jackson Laboratory is launching a new institute, JAX Genomic Medicine, later this year in Farmington, Connecticut. Ed Liu, JAX CEO and president, spoke on Friday at the Connecticut Science Center about the new institute and personalized medicine. 

    Feb 27, 2012

  • Biotech VC Woes Really Demand Growth, Not Supply Shortfall

    Pharmalot | Conventional wisdom says that biotech is a tough sell for venture capitalists these days, but new analysis shows a 16% increase over VC funding in 2011 compared to 2010, and a stunning 90% increase year to year in the last quarter. 

    Feb 27, 2012

  • February New Products

    Bio-IT World | New products for February including Life Technologies' new Ion Proton sequence, new NGS analysis software from Integromics, new products for clinical trial randomization and patient enrollment tracking, and new product lines specifically for patient-specific molecular and genomic data.  

    Feb 26, 2012

  • Complete Genomics Announces Software Partners

    MSNBC | Complete Genomics has introduced its Genomic Discovery Software Partners Program, which currently includes Ingenuity Systems, Golden Helix, and DNAnexus.

    Feb 23, 2012

  • Integromics Intends to Reign Beyond Spain

    Bio-IT World | In the heated field of genomics and proteomics informatics providers, new Integromics CEO Michael McManus has his work cut out to grow the business in a much more inclement economic climate than the one he experiences on his frequent visits to company headquarters in Madrid. 

    Feb 23, 2012